AMAO76 Alleviates the Pressure for Amakem Therapeutics

Jack Elands, CEO for Amakem, talks about his company’s focus on a localized drug action platform, and details the company’s feature glaucoma product to lower intraocular pressure designated, AMAO76 rokinase inhibitor. Presenter: Jack Elands Dr. Jack Elands has been the CEO of Amakem since its inception. Before, Jack was CBO of Silicos, an informatics based…

Read More

New Injection Technology Sets the Standard for Icon BioSciences

William S. (Sandy) White, President & CEO for Icon BioSciences, discusses the company’s increasing portfolio of products that target most major therapeutic areas of ophthalmology. Stressing the importance of getting the correct drug, in the correct place, with the best clinical approach, Sandy details the progress of their latest products and briefly highlights their newest…

Read More

NPP Meets the Mark for Kala Pharmaceuticals

[creativ_media type=”vimeo” url=”https://vimeo.com/82003104″] Guillaume Pfefer, President & CEO, shares Kala Pharmaceutical’s breakthrough technology Nucleolus Penetrating Particle with the audience of the 5th Annual Ophthalmology Innovation Summit. Detailing how this technology benefits a variety of conditions, Guillaume explains how the NPP can be leveraged to treat, post cataract surgery inflammation, dry eye, plethoritis and a demonstration…

Read More

Novaliq Clears the Obstacles in Ocular Track Delivery

Bernhard Gunther, CEO for Novaliq GmbH, introduces their approach to improving topical ocular track delivery. Detailing the challenges involved, Bernhard expands on their unique opportunity to resolve these issues by dissolving poorly soluble tracks, with low viscosity and surface tension. Presenter: Bernhard Günther Bernhard Günther joined Novaliq as CEO in January 2007. He has more…

Read More

RXi Shortens Strands for Effective Drug Delivery

Geert Cauwenbergh, President & CEO for RXi Pharmaceuticals, shares the company’s role in making RNAI relevant to ophthalmology. Highlighting their research surrounding the delivery of drug to the eye, Geert expands on their unique modification to create shorter passenger strands to accompany the longer guide strand to facilitate delivery to the eye effectively. Presenter: Geert…

Read More

Clinical Overview of MIGS

Addressing the attendees at the 2nd Annual Ophthalmology Innovation Summit with a clinical overview of Micro-Invasive Glaucoma Surgery, Ike K. Ahmed, MD and Assistant Professor for the University of Toronto, details the transition from glaucoma medication to micro-invasive surgery and some of the devices contributing to the successes of this procedure. Presenter: Ike Ahmed, MD…

Read More